Anuh Pharma promoters hold 7.19 crore shares in FY26

1 min read     Updated on 28 May 2026, 05:47 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Anuh Pharma's promoters and promoter group held a total of 7,19,56,044 equity shares as of March 31, 2026, with no encumbrances reported during FY26. The disclosure, filed by Bharat Nemchand Shah, lists 37 entities in the promoter group, with Bharti Bipin Shah and Prafulla Lalit Shah being the largest shareholders.

powered bylight_fuzz_icon
41473016

*this image is generated using AI for illustrative purposes only.

Anuh Pharma Limited disclosed that its promoters and promoter group collectively held 7,19,56,044 equity shares as on March 31, 2026. Bharat Nemchand Shah, filing on behalf of all promoters, promoter group, and persons acting in concert, confirmed that no encumbrance was created on these shares during the financial year ended March 31, 2026. The filing was submitted to BSE Limited and National Stock Exchange of India Limited in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The detailed shareholding pattern of the promoter group was provided in Annexure-A to the disclosure. The list includes 37 entities ranging from individuals to Hindu Undivided Families (HUFs) and Limited Liability Partnerships (LLPs). Bharti Bipin Shah emerged as the largest holder within the group with 1,94,74,800 shares, followed by Prafulla Lalit Shah with 1,44,99,132 shares. Bipin Nemchand Shah, in his individual capacity, held 62,21,720 shares, while his HUF held 84,94,200 shares.

Shareholding Details

The following table outlines the shareholding distribution among the key members of the promoter and promoter group:

Name No of equity Shares held
Bharti Bipin Shah 1,94,74,800
Prafulla Lalit Shah 1,44,99,132
Bipin Nemchand Shah (HUF) 84,94,200
Bipin Nemchand Shah 62,21,720
Bharat Nemchand Shah 37,34,214
Gaurav Satish Shah 32,00,688
Vivek Bipin Shah 23,40,000
Samir Jayantilal Shah 17,25,004
Mrudula Jayantilal Shah 23,39,856
Dina Satish Shah 22,20,280

The disclosure confirms that the total shareholding of the promoter and promoter group stands at 7,19,56,044 equity shares. The document was signed by Bharat Nemchand Shah, Promoter and Director, on April 06, 2026. A copy of the disclosure was also marked to the Audit Committee of Anuh Pharma Limited.

Historical Stock Returns for Anuh Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-1.73%-1.00%-6.98%-5.55%-30.55%-32.22%

How might the absence of encumbrances on promoter shares influence investor confidence in Anuh Pharma's stability?

What are the potential implications of the concentrated promoter holding on the company's governance and decision-making?

Could the lack of encumbrances signal future plans for leveraging these shares for strategic acquisitions or investments?

Anuh Pharma reclassifies nine shareholders to public category

1 min read     Updated on 26 May 2026, 04:35 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Anuh Pharma Limited applied to exchanges on May 25, 2026 to reclassify nine shareholders from the promoter group to the public category under Regulation 31A of SEBI LODR Regulations, 2015. The shareholders, holding 0.95% of the paid-up capital, are immediate relatives of promoters no longer involved in management.

powered bylight_fuzz_icon
40739568

*this image is generated using AI for illustrative purposes only.

Anuh Pharma Limited has applied to the stock exchanges on May 25, 2026 to reclassify nine shareholders from the promoter group to the public category. The application follows a Board meeting held on May 20, 2026, which approved the requests received from these shareholders on May 19, 2026. The reclassification is sought under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The shareholders collectively hold 9,49,988 equity shares, representing 0.95% of the company's total paid-up share capital. The applicants include Kinjal Siddharth Jhaveri, who holds the largest portion among the applicants at 0.81%, and others such as Nina Vijay Shah and Hemant Babubhai Choksi.

Details of Shareholders Seeking Reclassification

The following table outlines the shareholders approved for reclassification along with their respective holdings:

Sr No. Name Number of Equity shares held % of shareholding
1. Madhurika Narendra Shah 12,000 0.01
2. Hemant Babubhai Choksi 24,000 0.02
3. Mukesh Kantilal Shah 14,400 0.01
4. Aruna Navnit Shah 5,040 0.01
5. Vikram Kirtilal Shah 200 0.00
6. Kiran Piyush Shah 15,388 0.02
7. Kinjal Siddharth Jhaveri 8,16,160 0.81
8. Nina Vijay Shah 60,000 0.06
9. Neela Pradeep Shah 2,800 0.003
TOTAL 9,49,988 0.95

Regulatory Compliance and Undertakings

The Board confirmed that these individuals are immediate relatives of promoters and are no longer involved in the day-to-day affairs or management of anuh pharma . They stated that they do not exercise control over the company's affairs or possess special rights through formal or informal arrangements.

The outgoing promoters confirmed they do not hold more than 10% of the total voting rights, are not represented on the Board of Directors, and do not act as key managerial personnel. They also verified that they are not wilful defaulters or fugitive economic offenders, and there is no pending regulatory action against them.

Historical Stock Returns for Anuh Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-1.73%-1.00%-6.98%-5.55%-30.55%-32.22%

How will the increase in public shareholding to 0.95% impact Anuh Pharma's ability to meet minimum public float requirements?

Does this reclassification signal a broader trend of promoter family members reducing their involvement in the company's management?

Could this shift in shareholding structure lead to changes in the company's corporate governance policies?

More News on Anuh Pharma

1 Year Returns:-30.55%